Dr. Ralph G. Cipriano

As a board-certified interventional cardiologist, Dr. Banerjee is internationally recognized for his expertise in minimally invasive treatments of coronary artery disease, peripheral artery disease and transcatheter aortic valve replacement. He is currently serving as the Paul J. Thomas Endowed Chair in Cardiology and chief of cardiovascular research and innovation for Baylor Scott & White Heart and Vascular Services-Dallas. Dr. Banerjee is the editor-in-chief of the American Journal of Cardiology, one of the premier cardiology journals in the world. He also serves as one of the founding directors of the Cardiovascular Innovations Foundation. He has led many landmark clinical trials, published over 450 peer-reviewed manuscripts, and is an invited faculty at national and international cardiovascular conferences. Dr. Banerjee is highly rated in 15 conditions, according to our data. His top areas of expertise are Peripheral Artery Disease, Atherosclerosis, Coronary Heart Disease, Atherectomy, and Angioplasty.

Dr. James Choi has been caring for Texas hearts since 2004. He is fellowship-trained in interventional cardiology. He is board-certified in internal medicine, cardiovascular disease, nuclear cardiology and interventional cardiology. Dr. Choi's areas of clinical interest and focus include cardiovascular disease in diabetic patients; highly complex cardiology interventions: left main coronary artery and chronic total occlusions; valvular heart interventions; structural heart interventions: ASD/PFO/Left atrial appendage closure; and peripheral vascular disease. He has published numerous articles and conducted clinical research on coronary stent implantation and chronic total occlusions as well as novel renal artery denervation treatment for resistant hypertension.Dr. Choi earned his medical degree from Northwestern University Medical School in Chicago, where he also completed his residency in internal medicine and fellowships in cardiology and interventional cardiology. He is the current medical director of Coronary, Renal and Structural Heart Technologies for the Baylor Research Institute in Dallas. He previously served as an associate professor in the Department of Internal Medicine at the Texas A&M Health Science Center College of Medicine in College Station and as the director of the Interventional Cardiology Fellowship at Baylor University Medical Center in Dallas.Dr. Choi is a Fellow of the American College of Cardiology and Society for Cardiovascular Angiography & Interventions. He currently chairs the DFW AngioClub and is a member of the American Heart Association, Texas Medical Association and Dallas County Medical Association. Dr. Choi has sat on numerous advisory boards, completed clinical research into various devices and cardiovascular procedures, and is active in the Korean-American medical community. Dr. Choi is highly rated in 28 conditions, according to our data. His top areas of expertise are Coronary Heart Disease, Angina, Heart Attack, Percutaneous Coronary Intervention (PCI), and Heart Bypass Surgery.

Dr. Ayman Samman Tahhan is a fellowship-trained interventional cardiologist. His areas of clinical interest and focus include cardiovascular disease, coronary artery disease, peripheral vascular disease, heart failure, valvular heart disease, lipid and cholesterol management. As an interventional cardiologist, Dr. Tahhan performs diagnostic exams and scans like ECGs, stress tests, echocardiography, ultrasound imaging, nuclear imaging, peripheral vascular testing radial cardiac catheterization, coronary intervention, peripheral vascular intervention and pulmonary embolus. Dr. Tahhan is a member of the American College of Cardiology, American College of Physicians, American Heart Association and Society for Cardiovascular Angiography and Interventions. He and his wife enjoy raising their two children. In his spare time, Dr. Tahhan cooks and plays soccer and table tennis. Dr. Tahhan is highly rated in 36 conditions, according to our data. His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pediatric Myocarditis, and Necrosis.